ExploreWatchlistsPricing
  1. JP-listed companies
  2. GNI Group Ltd.
  3. Financials
  4. Revenue

GNI Group Ltd. (2160)

Market cap
¥174.3B
P/E ratio
GNI Group develops and manufactures pharmaceuticals and medical devices, serving global markets with key products like Aisuryui in China and biomaterials in the US.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Dec 31, 202526,840+13.67%
Dec 31, 202423,612-9.22%
Dec 31, 202326,011+49.32%
Dec 31, 202217,419+37.26%
Dec 31, 202112,690+29.84%
Dec 31, 20209,774+31.26%
Dec 31, 20197,446+48.36%
Dec 31, 20185,019+89.50%
Dec 31, 20172,648+102.65%
Dec 31, 20161,307+28.55%
Dec 31, 20151,017+114.16%
Dec 31, 2014475+158.56%
Dec 31, 2013184+13.37%
Dec 31, 2012162+79.28%
Dec 31, 201190

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat